I am surprised that some still asking basic questions.1. We have...

I am surprised that some still asking basic questions.

1. We have 10mln people with - armlet excessive sweat ( or known as axcillary hyperhidrosis) - page 19of presentation
2. Out these 10mln > 3.7mln are known to doctors and already actively seeking treatments.

our strategy :

a. Attack 3.7mln with targeted sales force of20-30 ppl as it is concentrated with few hundred dermatologists

b. Attack delta ( 10mln- 3.7mln) = 6.3mln with telemedecine - slide 19...many people are shy and stigmatised to go to doctor ..online/ telemedicine will do the trick...

now, let's make some realistic assumptions:


1. From pool of 3.7mln people who actively seeking to fix arm pit sweat ( knowing that Japan does well and half of dermatologist are ready to prescribe Sofdra) - assume we get to 5% market in fist 12-18months

that is 185 000 patients

2. From 6.3mln pool of people - lets assume we get to 1% of this >> this is 63 000 patients


overall, it will give us 250 000 patients

or
1. Net Revenue ( after giving 15% to distributors e..g telemedicine group, dermatologists) usd 500 by 6 prescriptions by 250 000 patients = usd 750mln